SCHEMBL30447826

SCHEMBL30447826

Cc1ccc(S(=O)(=O)n2ncc3sc(C4=CCN(C(=O)OC(C)(C)C)CC4)cc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 3/20 0.52
▸ HTR6 P50406 1/20 0.48
▸ GPR119 Q8TDV5 1/20 0.47
▸ PDK4 Q16654 1/20 0.43
▸ GRM1 Q13255 9/20 0.41
▸ GRM5 P41594 8/20 0.41
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GABRA4 P48169 1/20 0.40
▸ GABRE P78334 1/20 0.40
▸ GABRA6 Q16445 1/20 0.40
▸ GABRG1 Q8N1C3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30447476 0.80 GPR119 (0.45) GPR119
SCHEMBL1417900 0.73 ESR2 (0.45) HTR6GPR119
SCHEMBL28668463 0.73 PDK4 (0.54) KITHTR6GPR119PDK4GRM1
SCHEMBL8912847 0.72 NAMPT (0.63) KITHTR6GPR119PDK4GRM1
SCHEMBL18080760 0.72 HTR6 (0.64) KITHTR6GPR119PDK4GRM1
SCHEMBL22777065 0.71 HTR6 (0.60) KITHTR6GPR119PDK4GRM1
SCHEMBL15555500 0.71 HTR6 (0.49) KITHTR6GPR119PDK4GRM1
SCHEMBL31189181 0.71 KIT (0.47) KITGPR119PDK4GRM1GRM5
SCHEMBL31189189 0.71 KIT (0.47) KITGPR119PDK4GRM1GRM5
SCHEMBL22324776 0.70 HTR6 (0.55) KITHTR6GPR119PDK4GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133229-A2 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-07-13 — — WO disclosed
EP-4178963-A1 5-[5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES Remix Therapeutics Inc. (US) 2023-05-17 — — EP disclosed
Send feedback